Veletri (Actelion Pharmaceuticals US, Inc.)


Welcome to the PulseAid listing for the Veletri drug offered from Actelion Pharmaceuticals US, Inc.. This Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actelion Pharmaceuticals US, Inc.
NON-PROPRIETARY NAME: epoprostenol sodium
SUBSTANCE NAME: EPOPROSTENOL SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-04-22
END MARKETING DATE: 0000-00-00


Veletri HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVeletri from Actelion Pharmaceuticals US, Inc.
LABELER NAME: Actelion Pharmaceuticals US, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1500000(ng/10mL)
START MARKETING DATE: 2010-04-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66215-401_c21fe239-6ac6-46a2-b97c-84d9ad1a5c98
PRODUCT NDC: 66215-401
APPLICATION NUMBER: NDA022260

Other EPOPROSTENOL SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actelion Pharmaceuticals US, Inc.Veletri
GlaxoSmithKline LLCFLOLAN
Teva Parenteral Medicines, Inc.Epoprostenol Sodium